Received Apr 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 2 | T5D73 | IM / LA |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 2 | Y011637 | SC / LA |
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | 1 | AMVB030A | IM / LA |
Client received adult Engerix -B formulation instead of the pediatric/ adolescent Engerix-B as a 19-year-old. No adverse side effects observed nor reported.
UNK
N/A
UNK
NKA
N/A